摘要
目的评价23价肺炎球菌多糖疫苗大面积使用的临床安全性。方法对接种23价肺炎球菌多糖疫苗的受种者发放监测卡,30 d以后回收监测卡,统计局部及全身反应情况,收集罕见不良反应。结果观察共接种6 550人,回收有效监测卡4 361张,局部反应发生率0.71%,全身反应发生率1.56%,未见罕见和极罕见不良反应。结论国产23价肺炎球菌多糖疫苗上市后大面积使用是安全的。
Objective To evaluate the clinical safty of 23 valent pneumococcal polysaccharide vaccine for large area use.Methods Inspect cards were sent to the people who received 23 valent pneumococcal polysaccharide vaccine,and retrieved the cards after 30 days.Statistics of partial and systemic reactions,collection of rare adverse reactions were carried out.Results A total of 6 550 person received 23 valent pneumococcal polysaccharide vaccine,with 4 361 available inspect cards retrieved.The incidence of local adverse reaction was 0.71%,of systemic adverse reaction was 1.56%.There was no rare adverse reaction observed.Conclusion The 23 valent pneumococcal polysaccharide vaccine made in China is safe for large scale vaccination.
出处
《职业卫生与病伤》
2011年第5期270-272,共3页
Occupational Health and Damage
关键词
23价肺炎球菌多糖疫苗
安全性
23 valent pneumococcal polysaccharide vaccine
safety
